T1	HMM 155 174	efficacy and safety
T2	HMM 862 895	biopsy-confirmed acute rejections
T3	HMM 984 1031	incidence of steroid-sensitive acute rejections
T4	HMM 1088 1122	Steroid-resistant acute rejections
T5	HMM 1220 1225	died.
T6	HMM 1226 1261	Patient survival and graft survival
T7	HMM 1409 1436	incidence of adverse events
T8	HMM 1452 1483	cytomegalovirus (CMV) infection
T9	HMM 1537 1547	leukopenia
T10	HMM 1575 1580	fever
T11	HMM 1609 1623	herpes simplex
T12	HMM 1655 1671	thrombocytopenia
T13	HMM 1723 1737	serum sickness
T14	HMM 1790 1817	new onset diabetes mellitus
T15	HMM 1893 1908	acute rejection
T16	HMM 2063 2077	adverse events
T17	HMM 2092 2106	CMV infection.
